Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Trilogy Tissue Marker

K-Number: K240429 · 2024-11-07

ApplicantInrad, Inc.
Decision Date2024-11-07
Product CodeNEU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Trilogy Tissue Marker is a medical device manufactured by Inrad, Inc.. It received FDA 510(k) clearance on 2024-11-07 under approval number K240429. The device is classified under product code NEU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Trilogy Tissue Marker?

Trilogy Tissue Marker is a medical device that received FDA 510(k) clearance on 2024-11-07. It is manufactured by Inrad, Inc.. The 510(k) number is K240429.

When was Trilogy Tissue Marker approved by the FDA?

Trilogy Tissue Marker received FDA 510(k) clearance on 2024-11-07, under approval number K240429.

What company makes Trilogy Tissue Marker?

Trilogy Tissue Marker is manufactured by Inrad, Inc..

What is the FDA product code for Trilogy Tissue Marker?

The FDA product code for Trilogy Tissue Marker is NEU.

Related Clinical Trials

Other Devices by Inrad, Inc.

Related Devices (Code: NEU)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.